HOME PRODUCTS COMPANY CONTACT FAQ

Research Dictionary Pharma

Sign Up FREE or Login

5,10,15,20- tetrakis(N- methyl- 4'- pyridyl)porphyrinato- iron(III)

Also Known As:

FeTM-4-PyP; FeTMPyP cpd

Networked: 1 relevant articles (0 outcomes, 0 trials/studies)

Bio-Agent Context: Research Results

Organic Chemicals: 133
- Coordination Complexes: 576
  - Metalloporphyrins: 178
    - 5,10,15,20-tetrakis(N-methyl-4'-pyridyl)porphyrinato-iron(III): 1
Heterocyclic Compounds: 198
- 1-Ring Heterocyclic Compounds
  - Azoles: 2138
    - Pyrroles: 369
      - Tetrapyrroles: 70
        Porphyrins: 3316
        Metalloporphyrins: 178
        5,10,15,20-tetrakis(N-methyl-4'-pyridyl)porphyrinato-iron(III): 1
- Fused-Ring Heterocyclic Compounds
  - 4 or More Rings Heterocyclic Compounds
    - Tetrapyrroles: 70
      - Porphyrins: 3316
        Metalloporphyrins: 178
        5,10,15,20-tetrakis(N-methyl-4'-pyridyl)porphyrinato-iron(III): 1
Polycyclic Compounds: 6
- Macrocyclic Compounds: 15
  - Tetrapyrroles: 70
    - Porphyrins: 3316
      - Metalloporphyrins: 178
        5,10,15,20-tetrakis(N-methyl-4'-pyridyl)porphyrinato-iron(III): 1
Biological Factors: 2472
- Biological Pigments: 1
  - Porphyrins: 3316
    - Metalloporphyrins: 178
      - 5,10,15,20-tetrakis(N-methyl-4'-pyridyl)porphyrinato-iron(III): 1

Experts

1.	Kaul, Chaman L: 1 article (10/2004)
2.	Munusamy, Shankar: 1 article (10/2004)
3.	Sharma, Shyam S: 1 article (10/2004)
4.	Thiyagarajan, Meenakshisundaram: 1 article (10/2004)

Related Diseases

1.	Middle Cerebral Artery Infarction (Middle Cerebral Artery Syndrome) 10/01/2004 - "The authors evaluated the neuroprotective effect of 5,10,15,20-tetrakis(N-methyl-4'-pyridyl)porphyrinato-iron(III) (FeTMPyP), a peroxynitrite decomposition catalyst, and 1,5-isoquinolinediol (ISO), a poly(adenosine diphosphate [ADP]-ribose) polymerase (PARP) inhibitor, alone and in combination in rats with focal cerebral ischemia induced by middle cerebral artery occlusion (MCAO). "
2.	Brain Ischemia (Cerebral Ischemia) 10/01/2004 - "The authors evaluated the neuroprotective effect of 5,10,15,20-tetrakis(N-methyl-4'-pyridyl)porphyrinato-iron(III) (FeTMPyP), a peroxynitrite decomposition catalyst, and 1,5-isoquinolinediol (ISO), a poly(adenosine diphosphate [ADP]-ribose) polymerase (PARP) inhibitor, alone and in combination in rats with focal cerebral ischemia induced by middle cerebral artery occlusion (MCAO). "

Related Drugs and Biologics

1.	Peroxynitrous Acid (Peroxynitrite)
2.	Neuroprotective Agents
3.	Poly(ADP-ribose) Polymerases (Poly ADP Ribose Polymerase)
4.	Adenosine Diphosphate Ribose (ADP-Ribose)
5.	Adenosine Diphosphate (ADP)
6.	1,5-dihydroxyisoquinoline